Salonen A, Silvola J, Kokki H
Department of Otorhinolaryngology, Päijät-Häme Central Hospital, FI-15850 Lahti, Finland.
Acta Anaesthesiol Scand. 2009 Oct;53(9):1200-6. doi: 10.1111/j.1399-6576.2009.02035.x. Epub 2009 Jun 30.
We have evaluated whether co-administration of intravenous (i.v.) paracetamol could enhance the analgesic efficacy of ketoprofen (a non-steroidal anti-inflammatory drug or NSAID) in patients undergoing a tonsillectomy.
This prospective, randomized, double-blinded and placebo-controlled add-on study with three parallel groups included 114 patients, aged 16-50 years, and scheduled for elective tonsillectomy. All patients were given ketoprofen 1 mg/kg i.v. after surgery, followed 5 min later by paracetamol 1 or 2 g i.v., or normal saline as a placebo. The primary outcome measure was the proportion of patients requiring oxycodone for rescue analgesia over the first 6 h (pain score >30/100 mm at rest or >50/100 mm during swallowing) after surgery.
No difference was detected in the proportion of patients receiving oxycodone (31/37 in the paracetamol 1 g group, 29/39 in the paracetamol 2 g group and 30/38 in the ketoprofen-alone group) between the three groups. However, significantly less doses of rescue analgesia were provided in the paracetamol groups than in the ketoprofen-alone group (P=0.005); among those who required rescue analgesia, 27% less oxycodone was required in the paracetamol 1 g group (80 doses, P=0.023) and 38% less in the paracetamol 2 g group (64 doses, P=0.002) than in the ketoprofen-alone group (106 doses).
Combining paracetamol i.v. with ketoprofen at the end of tonsillectomy did not reduce the proportion of the patients requiring rescue analgesia, but the number of opioid doses was less in the add-on groups.
我们评估了静脉注射对乙酰氨基酚联合使用是否能增强酮洛芬(一种非甾体抗炎药或NSAID)对扁桃体切除患者的镇痛效果。
这项前瞻性、随机、双盲且安慰剂对照的附加研究设有三个平行组,纳入了114例年龄在16至50岁、计划进行择期扁桃体切除术的患者。所有患者术后静脉注射1mg/kg酮洛芬,5分钟后再静脉注射1g或2g对乙酰氨基酚,或注射生理盐水作为安慰剂。主要观察指标是术后前6小时内(静息时疼痛评分>30/100mm或吞咽时>50/100mm)需要使用羟考酮进行补救镇痛的患者比例。
三组之间接受羟考酮治疗的患者比例没有差异(对乙酰氨基酚1g组为31/37,对乙酰氨基酚2g组为29/39,单独使用酮洛芬组为30/38)。然而,对乙酰氨基酚组提供的补救镇痛剂量明显少于单独使用酮洛芬组(P=0.005);在需要补救镇痛的患者中,对乙酰氨基酚1g组所需的羟考酮比单独使用酮洛芬组少27%(80剂,P=0.023),对乙酰氨基酚2g组少38%(64剂,P=0.002)(单独使用酮洛芬组为106剂)。
扁桃体切除术后静脉注射对乙酰氨基酚与酮洛芬联合使用并没有降低需要补救镇痛的患者比例,但附加用药组的阿片类药物剂量较少。